國立虎尾科技大學 |

Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems / edited by Jayvadan K. Patel, Yashwant V. Pathak.
other author:	Patel, Jayvadan K.
Description:	XIII, 438 p. 102 illus., 84 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Drug delivery systems. -
Online resource:	https://doi.org/10.1007/978-3-030-83395-4
ISBN:	9783030833954

Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems [electronic resource] /edited by Jayvadan K. Patel, Yashwant V. Pathak. - 1st ed. 2022. - XIII, 438 p. 102 illus., 84 illus. in color.online resource.

Part 1-Modelling of PK/PD for NPDDS -- Introduction to Nanoparticulate Drug Delivery Systems -- Nanoparticle Properties Affecting Pharmacokinetics of NPDDS -- Models Used for Biopharmaceutical Evaluation of NPDDS -- Models Used in the Pharmacokinetic Evaluation of NPDDS -- Models Used in the Pharmacodynamic Evaluation of NPDDS -- Preclinical Animal Models For Experimental Design of Pharmacokinetic Studies of NPDDS -- Pharmacokinetic Modelling Program (PKMP) -- Part 2-PK/PD for Specific Nanocarriers -- Pharmacokinetic and Pharmacodynamics of Liposomal Nanoparticles -- Pharmacokinetics of Polymer Matrix Drugs (NPDDS) -- Pharmacokinetics of Long-Circulating NPDDS -- Metallic Gold Nanoparticles in vivo Pharmacokinetics and X-ray Contrast imaging Studies -- Muco-adhesive NPDDS In Vitro and Pharmacokinetics Studies -- Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles -- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles -- PKPD of PLGA-PEG-PLGA Triblock CoPolymeric Micelles -- Part 3-PKPD in Diseased Conditions for NPDDS -- Bridging Bio-Nanoscience and Cancer Nanomedicine -- Clearance Pathways and Tumor Targeting of Imaging Nanoparticles for Diagnostics -- PLGA Nanoparticles for Oral Delivery-Nephrotoxicity and Pharmacokinetic Studies -- Pharmacokinetics of Nanoparticle Systems for Pulmonary Delivery -- In vivo Biodistribution and Pharmacokinetic Studies of NPDDS for Brain Targeting -- Enhanced Bioavailability and Intestinal Uptake Nanoparticles After Oral Delivery -- Nanoparticle Pharmacokinetic Profiling In Vivo Using Magnetic Resonance Imaging.

A reference is needed that addresses the recent progress in aspects of PK/PD methods and developments of nanoparticles for novel drug delivery systems. No other consolidated published reference discusses the PK/PD study of nanoparticle drug delivery systems. This book discusses the advantages of nanoparticle drug delivery systems (NPDDS) in enhancing the pharmacokinetics of many drugs that are not easily metabolized or that obtain the desired therapeutic effect with minimum toxicity. The authors provide an overview of biodistribution with a focus on polymer and lipid nanoparticles. This thorough reference is divided into three parts: Modelling, Specific carries and their potential to treat specific diseases.

ISBN: 9783030833954

Standard No.: 10.1007/978-3-030-83395-4doiSubjects--Topical Terms:

581921
Drug delivery systems.

LC Class. No.: RS199.5

Dewey Class. No.: 615.6

Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
LDR:03758nam a22003975i 4500 001 1089665
003 DE-He213
005 20220307070627.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030833954 $9 978-3-030-83395-4
024 7 $a 10.1007/978-3-030-83395-4 $2 doi
035 $a 978-3-030-83395-4
050 4 $a RS199.5
072 7 $a TCB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 615.6 $2 23
245 1 0 $a Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems $h [electronic resource] / $c edited by Jayvadan K. Patel, Yashwant V. Pathak.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XIII, 438 p. 102 illus., 84 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part 1-Modelling of PK/PD for NPDDS -- Introduction to Nanoparticulate Drug Delivery Systems -- Nanoparticle Properties Affecting Pharmacokinetics of NPDDS -- Models Used for Biopharmaceutical Evaluation of NPDDS -- Models Used in the Pharmacokinetic Evaluation of NPDDS -- Models Used in the Pharmacodynamic Evaluation of NPDDS -- Preclinical Animal Models For Experimental Design of Pharmacokinetic Studies of NPDDS -- Pharmacokinetic Modelling Program (PKMP) -- Part 2-PK/PD for Specific Nanocarriers -- Pharmacokinetic and Pharmacodynamics of Liposomal Nanoparticles -- Pharmacokinetics of Polymer Matrix Drugs (NPDDS) -- Pharmacokinetics of Long-Circulating NPDDS -- Metallic Gold Nanoparticles in vivo Pharmacokinetics and X-ray Contrast imaging Studies -- Muco-adhesive NPDDS In Vitro and Pharmacokinetics Studies -- Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles -- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles -- PKPD of PLGA-PEG-PLGA Triblock CoPolymeric Micelles -- Part 3-PKPD in Diseased Conditions for NPDDS -- Bridging Bio-Nanoscience and Cancer Nanomedicine -- Clearance Pathways and Tumor Targeting of Imaging Nanoparticles for Diagnostics -- PLGA Nanoparticles for Oral Delivery-Nephrotoxicity and Pharmacokinetic Studies -- Pharmacokinetics of Nanoparticle Systems for Pulmonary Delivery -- In vivo Biodistribution and Pharmacokinetic Studies of NPDDS for Brain Targeting -- Enhanced Bioavailability and Intestinal Uptake Nanoparticles After Oral Delivery -- Nanoparticle Pharmacokinetic Profiling In Vivo Using Magnetic Resonance Imaging.
520 $a A reference is needed that addresses the recent progress in aspects of PK/PD methods and developments of nanoparticles for novel drug delivery systems. No other consolidated published reference discusses the PK/PD study of nanoparticle drug delivery systems. This book discusses the advantages of nanoparticle drug delivery systems (NPDDS) in enhancing the pharmacokinetics of many drugs that are not easily metabolized or that obtain the desired therapeutic effect with minimum toxicity. The authors provide an overview of biodistribution with a focus on polymer and lipid nanoparticles. This thorough reference is divided into three parts: Modelling, Specific carries and their potential to treat specific diseases.
650 0 $a Drug delivery systems. $3 581921
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Pharmaceutical chemistry. $3 581965
650 0 $a Pharmacology. $3 583819
650 1 4 $a Drug Delivery. $3 1366630
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Pharmaceutics. $3 1366841
700 1 $a Patel, Jayvadan K. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1210041
700 1 $a Pathak, Yashwant V. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1279442
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030833947
776 0 8 $i Printed edition: $z 9783030833961
776 0 8 $i Printed edition: $z 9783030833978
856 4 0 $u https://doi.org/10.1007/978-3-030-83395-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)